iiinova — where your digital self keeps evolving

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 31/07/2026

We have selected @Asana software to manage our group activity. Recently, a waiver with a 50% discount has succesfully been applied to our group as a non-profit organization supported by the @ecnp.eu Networks board. We are thankful to both to facilitate innovation in science for clinical trials.

000

Reposted by Neuroscience Outcomes Hub

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 24/07/2026

New webinar available on Clinical Outcomes for Interventional Studies by @szaragozad.bsky.social Chair of Network at the @ecnp.eu Just 40 minutes to learn basic principles in clinical trials design and outcomes strategy. knowledge-hub.ecnp.eu/webcasts/hea...

knowledge-hub.ecnp.eu

Health Outcomes Strategy in Interventional Studies | ECNP Knowledge Hub

012

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 24/07/2026

knowledge-hub.ecnp.eu

Health Outcomes Strategy in Interventional Studies | ECNP Knowledge Hub

012

Reposted by Neuroscience Outcomes Hub

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 13/07/2026

New paper accepted on Neurodevelopment Rare Diseases Clinical trials. Amazing work to offer expert’s opinion of 36 co-authors. Supplementary data includes a checklist of challenges to considere. @ecnp.eu authors.elsevier.com/sd/article/S...

021

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 13/07/2026

021

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 05/06/2026

New publication of our group at Applied Neurosciences Special Section dealing with "Olfactory impairment in Huntington's disease: A systematic review and meta-analysis" co-authored by Franco di Cesare from our Network thanks to @ecnp.eu for all your support! www.sciencedirect.com/science/arti...

sciencedirect.com

Olfactory impairment in Huntington's disease: A systematic review and meta-analysis

Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder characterised by progressive impairment in cognitive, behavioural, and m…

010

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 02/06/2026

#NeurosciencesApplied dedicated an Issue to Clinical Outcomes Sciencies offering five papers about hot topics. The foutj paper is available: "Clinical Trials in Neurosciences: Need for Standards for Innovation on Clinical Outcomes” www.sciencedirect.com/science/arti... @ecnp.eu

sciencedirect.com

Clinical Trials in Neurosciences: Need for Standards for Innovation on Clinical Outcomes

Advances in understanding neurobiological factors underlying neurologic and psychiatric conditions have yet to be adequately translated into successfu…

020

Reposted by Neuroscience Outcomes Hub

ECNP @ecnp.eu · 02/06/2026

𝗧𝗵𝗲 𝗴𝗿𝗼𝘄𝗶𝗻𝗴 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗴𝗮𝗽 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗽𝘀𝘆𝗰𝗵𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝘆 New psychiatric treatments are advancing globally—but only a few reach patients across Europe. ECNP is working to help close this gap. 🔎 ow.ly/nZTx50Z6wMj #MentalHealth #Psychiatry #Innovation #HealthcarePolicy #ECNP #ECNP2026

021

Reposted by Neuroscience Outcomes Hub

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 22/05/2026

Webinar Series "From Data to Value" held by our Network and organized by @ecnp.eu, firs webinar now available on demand at the Knowledge Hub a knowledge-hub.ecnp.eu/webcasts/dig... Do not loose the opportunity to clarify concepts in this field. Ask the expert @georgdorffner

knowledge-hub.ecnp.eu

Digital health technology and AI for trial endpoints | ECNP Knowledge Hub

011

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 22/05/2026

knowledge-hub.ecnp.eu

Digital health technology and AI for trial endpoints | ECNP Knowledge Hub

011

Reposted by Neuroscience Outcomes Hub

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 17/05/2026

🤩 Not yet registered? Free webinar to learn how to innovate on clinical trials from novel endpoints based on AI/ML technology 😉 We start by clarifying concepts bu Georg Dorffner. ihttps://knowledge-hub.ecnp.eu/webinar/digital-health-technology-and-ai-trial-endpoints

knowledge-hub.ecnp.eu

Digital health technology and AI for trial endpoints | ECNP Knowledge Hub

011

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 17/05/2026

knowledge-hub.ecnp.eu

Digital health technology and AI for trial endpoints | ECNP Knowledge Hub

011

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 15/05/2026

#NeurosciencesApplied dedicated an Issue to Clinical Outcomes Sciencies offering five papers about hot topics. The third paper is available: "Negative Symptoms in Schizophrenia: Methodological Challenges and Emerging Solutions for Outcome Measurement" www.sciencedirect.com/science/arti... @ecnp.eu

sciencedirect.com

Negative Symptoms in Schizophrenia: Methodological Challenges and Emerging Solutions for Outcome Measurement

Negative symptoms (NS) affect approximately 60% of individuals with schizophrenia and are associated with poor outcomes. They remain an important unme…

000

Reposted by Neuroscience Outcomes Hub

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 09/05/2026

Our paper “Negative Symptoms in Schizophrenia: Methodological Challenges and Emerging Solutions for Outcome Measurement” by Armida Mucci et al., has been accepted for publication at Neuroscience Applied @ecnp.eu journal. This is the third paper published as Special Issue dedicated to Outcomes in CT

011

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 09/05/2026

011

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 02/05/2026

Our Network offers opportunities to junior scientific Project Managers (jsPM) to get involved in subgroups working hands on with KOLs in specific topics for a short period of tine. Contact @igormagaraggia.bsky.social or @szaragozad.bsky.social for more information @ecnp.eu @acnporg.bsky.social

information.ecnp.eu

001

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 28/04/2026

Congratulations to our Subgroup on Cognition KoM today setting goals and team building moving forward! Lead by Chris Edgar supported by @imagaraggia and @Katerina Stravoravi. During next couple of weeks we all 7 network members will send suggestions to shape actions.

100

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 17/04/2026

From Data to Values - Webinar Series Register to May webinar on the use of AI/ML on outcomes research by G. dorffner. knowledge-hub.ecnp.eu/webinar/digi...

knowledge-hub.ecnp.eu

Digital health technology and AI for trial endpoints | ECNP Knowledge Hub

000

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 13/04/2026

Successful quarterly meeting with more than 40 attendants. Thank you to all members fort this huge participation!

000

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 11/04/2026

Glad that our network submitted four proposals to the 40th ECNP 2027 meeting in Barcelona. Excited to see the outcome of this effort! We will post as soon we know. Relevance of outcome strategy in clinical research needs to be acknowledged! @cpathinstitute.bsky.social

010

Reposted by Neuroscience Outcomes Hub

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 10/04/2026

We are ready for our FIRST QUARTERLY meeting next monday April 13th. Within the agenda we have an update of the activity by the Chair and Co-Chair, followed by a deep Appraisal on PANSS used in Schizophrenia clinical trials, presented by Anzalee Kahn. Join us if interested 👍send a DM in advance.

021

Reposted by Neuroscience Outcomes Hub

ECNP @ecnp.eu · 09/04/2026

✨The ECNP Scientific Programme Committee is meeting today to prepare an exceptional scientific programme for the #ECNP2027 Congress in Barcelona, Spain, 25–28 September 2027. 🎉A special edition as we celebrate ECNP’s 40th anniversary: four decades of advancing #BrainResearch together. #neuroscience

The ECNP Scientific Programme Committee is meeting today to prepare an exceptional scientific programme for the 40th ECNP Congress in Barcelona, Spain, 25–28 September 2027.

132

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 10/04/2026

021

Neuroscience Outcomes Hub @neuroscience-coa.bsky.social · 07/04/2026

ERDERA Grant Application has been submitted today for NEWCOMS CONNECT project. Congratulations to @fundaciondravet.bsky.social for all the effort done preparing the consortia and making the proposal so exciting for a more healthy society. Big Thanks! #rarediseases #coa #neurosciences #outcomes

150